Berlin, 20 October 2025 — The European Alliance for Personalised Medicine (EAPM) brought together experts from across Europe at ESMO 2025 for an interactive roundtable examining how behavioural science, digital innovation, and precision oncology can work together to reshape cancer prevention and care. A key highlight of the discussion was the Horizon Europe project iBeChange, […]

On 15 July, iBeChange was presented at the European Parliament during the event “Every Second Counts – Modernising Cancer Screening to Save Lives”, hosted by Seán Kelly MEP and organised by the European Alliance for Personalised Medicine (EAPM). We were honoured to be among a select group of EU4Health-funded projects invited to take part in

This week, the iBeChange team hosted its first user focus group at the Catalan Institute of Oncology (ICO)—a key milestone in our commitment to user-centred development. The session brought together a diverse group of participants who generously shared their personal experiences, preferences, and insights to help shape the iBeChange app. Their feedback touched on everything

April 29, 2025 – The iBeChange coordinating team from the Istituto Europeo di Oncologia (IEO) took part in the EU Health Policy Platform (EUHPP) Live Webinar titled “EU Cancer Mission – Cancer Prevention: Implementation Research and Behavioural Change.” This high-level event gathered researchers, policymakers, and public health experts to exchange ideas and strategies focused on

Milan, March 26–27, 2025 — The Politecnico di Milano hosted a dynamic two-day technical meeting of the iBeChange project, bringing together leading European researchers, clinicians, and technical experts united by a shared mission: transforming cancer prevention through behavioral science and technology. Over the course of the event, partners engaged in deep, collaborative discussions to refine

Milan, February 4th, 2025 — On World Cancer Day, the EU-funded iBeChange initiative has issued a powerful call to action for urgent, coordinated efforts to prevent cancer through innovation, collaboration, and behavior change. As part of this message, the project has launched two new white papers that offer fresh insights and policy recommendations: Supported by

Brussels, April 25th, 2024: Nearly half of all cancers may indeed be preventable, as health authorities routinely – andcorrectly – proclaim, but prevention depends largely on the behaviour of citizens. And so far, it has been proveddifficult to exert much beneficial influence in Europe to turn this huge opportunity into reality. That is why a

The iBeChange project, spearheaded by the European Institute of Oncology (IEO), officially kicked off its first day of meetings, laying the groundwork for the ambitious collaboration aimed at transforming behavioral health through an innovative integrated platform. The meeting commenced with a warm welcome from the project’s Principal Investigator, Gabriella Pravettoni, and Project Officer, Maria Grazia